NASDAQ NMS - GLOBAL MARKET · ESLA
0.00% · $0.0000 · Vol Not reported
Market closed · last close shown
Estrella Immunopharma Inc

Estrella Immunopharma Inc

Biotechnology
$0.4193
Card
Relationship Map

Follow $ESLA

One email when a member of Congress discloses a trade in it, with the official filing receipt linked.

Free. No account. Unsubscribe in one click.

Follow $ESLA by email

Veridion Score

BETAHIGH CONF · 6 of 6 factors measuredMethodology
ESLA
Estrella Immunopharma Inc
Wed Oct 7 · last completed session · Pre-market · regular session opens 9:30 ET
Lowest range

Highest qualified requires a score of at least 75 and high confidence, including full factor coverage. Upper range can hold a higher score with lower confidence.

Composite intelligence score across six company factor categories. Missing inputs are excluded from the active factor subset.

16/ 100
Veridion Score
Lowest range · HIGH confidence · 6 of 6 factors measured
Sovereign · $25/mo
See why this score moved.
  • · Factor breakdown with raw signals
  • · Day-over-day delta + driver
  • · Factor coverage readout
  • · Valuation · hype · market flow
  • · Pro Chart event markers
  • · Score history + alerts
Start Sovereign · $25/mo →
Cancel anytime · or Reserve · $79/mo
Confidence: HIGH · 6 of 6 factors measured · Wed Oct 7 · last completed session · Pre-market · regular session opens 9:30 ET
Share on X →
Veridion Score History · 90D
Loading score history
AI Analysis
Sovereign

Why is ESLA moving today?

Sovereign unlock connects news, insider activity, analyst moves, and live price action.
Loading ESLA catalysts
About Estrella Immunopharma Inc
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Listed since
2023
Country
US

Estrella Immunopharma Inc is a clinical-stage biopharmaceutical company. The company is engaged in developing CD19 and CD22-targeted ARTEMIS T-cell therapies with the capacity to address treatment challenges for patients with blood cancers and solid tumors.

Company website →
Key statistics

Reported fields plus Veridion-computed history. Unsourced tiles are omitted.

Open
$0.4193
Last session
Day high
$0.4193
Last session
Day low
$0.4193
Last session
Previous close
$0.4193
52W high
$3.05
-86.25% from high
52W low
$0.4193
0% of range
Market cap
$18.7M
EPS
$-0.2536
Beta
-0.85
Shares out
43.5M
Avg volume
39.4K
VWAP
$0.4193
Last session
Price history computed in-house
1W
-11.73%
1M
-34.52%
3M
-54.76%
1Y
-67.75%
YTD
-73.12%
SMA 50 $0.6346 · below
SMA 200 $1.06 · below
52W position 0%

ESLA overview

Veridion Score
16
Registered · 2026-10-07
6 of 6 factors measured
Latest receipt rows
0
No recent disclosure on file.
13F holders
None on file

Related filings and maps

Relationship mapTrace receipt-backed holders and filings around ESLA.Congress trackerSearch the public STOCK Act disclosure ledger.MethodologyReview score inputs, coverage rules, and limitations.
Loading financial statements
Loading ESLA Form 4 filings
Public disclosures

Congress activity in ESLA

Congress trackerOpen ticker disclosure ledger →

Congress disclosures unavailable.

Federal contracts

ESLA contract awards, year to date.

Public federal awards linked to this ticker.

Not disclosed
Refresh interval: 12hSource: Federal contract awards
No federal contracts on file for ESLA in this window.
Lobbying spend

ESLA lobbying filings, year to date.

Registered lobbying filings matched to Estrella Immunopharma Inc.

Not disclosed
Refresh interval: 12hSource: LDA disclosure filings
No lobbying filings on file for ESLA in this window.
Loading news for ESLA
Analyst ratings
Sovereign unlock shows live analyst consensus for ESLA.
Options
Options data is temporarily unavailable. Changing your plan will not restore the upstream feed.
Weekly Veridion brief

Rating changes, public disclosure activity, methodology notes, and product updates. One email per week. No advertising list resale.